🔗 Share this article

Chancellor Reeves has announced she is planning "focused steps to tackle cost of living pressures" in next month's Budget.

During an interview with media outlets, she emphasized that lowering inflation is a collective task of both the government and the central bank.

The UK's price growth is projected to be the most elevated among the Group of Seven industrialized countries this year and the following year.

Possible Energy Bill Interventions

Sources suggest the government could intervene to reduce energy bills, for instance by reducing the current 5% rate of VAT charged on energy supplies.

A further approach is to lower some of the regulatory levies currently added to bills.

Budgetary Limitations and Analyst Predictions

The administration will receive the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for such measures.

The view from the majority of experts is that Reeves will have to announce tax increases or spending cuts in order to meet her voluntary debt limits.

Previously on the same day, calculations showed there was a twenty-two billion pound deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"There's a joint task between the Bank of England and the government to continue tackling some of the sources of price increases," Reeves told the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Issues

While much of the focus has been on likely tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not changed her commitment to campaign commitments not to raise rates on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with growing international and commercial tensions for the fiscal revenue measures, probably to be targeted on those "most able to pay."

International Trade Disputes

Commenting on worries about the UK's economic relations with the Asian nation she said: "Our security interests invariably take priority."

Last week's declaration by China to tighten trade restrictions on critical minerals and other resources that are key for high-technology manufacturing led US President Donald Trump to suggest an further 100% tariff on imports from China, raising the prospect of an all-out commercial conflict between the two largest economies.

The American finance chief labeled China's move "commercial pressure" and "a international production power grab."

Inquired about accepting the American proposal to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "bad for the international commerce and causes additional obstacles."

"In my view there are fields where we need to challenge China, but there are also significant chances to trade with China's economy, including financial services and other areas of the economic system. We've got to achieve that equilibrium appropriate."

The chancellor also confirmed she was cooperating with international partners "on our own critical minerals approach, so that we are less reliant."

NHS Drug Costs and Investment

The Chancellor also recognized that the price the NHS spends on pharmaceuticals could rise as a consequence of current talks with the US government and its drugs companies, in exchange for lower tariffs and capital.

Some of the biggest global drug companies have said recently that they are either delaying or canceling projects in the United Kingdom, with several blaming the low prices they are obtaining.

Recently, the Science Minister said the cost the NHS spends on medicines would have to increase to prevent companies and pharmaceutical investment departing from the UK.

The Chancellor informed the BBC: "It has been observed due to the payment system, that drug testing, recent pharmaceuticals have not been available in the UK in the extent that they are in other EU nations."

"Our aim is to ensure that people getting treatment from the NHS are able to access the finest critical treatments in the globe. And so we are examining this situation, and... seeking to attract more investment into the UK."